Variables (measure) | CG | IG | p |
---|---|---|---|
Adherence (%) | 41.9 | 40.3 | 0.843* |
Sex (% males) | 91.9% | 91.7% | 0.96* |
Age (years) | 68.59 (66.4-70.78) | 69.57 (67.74-71.4) | 0.509** |
Low Educational Level | 81% | 75% | 0.683* |
Current Smoking (%) | 33.8% | 30.6% | 0.676* |
Smoking history (Pack-years) | 58.67 (48.68-68.66) | 67.07 (55.88-78.26) | 0.275** |
Cigarettes/day | 21.32 (19.3-23.34) | 19.45 (15.87-23.03) | 0.683** |
BMI (Kg/m2) | 31.42 (27.47-35.37) | 30.11 (29.06-31.16) | 0.538** |
Comorbidity | |||
• HBP (%) | 40 | 58,3 | 0.032* |
• DM (%) | 25.7 | 38.9 | 0.088* |
• OA (%) | 33.8 | 29.2 | 0.548* |
Diagnosis time (years) | 4.27 (3.57-4.97) | 4.61 (3.63-5.59) | 0.585** |
Pattern (%) | 0.673* | ||
• Obstructive | 47.8 | 54.9 | |
• Restrictive | 13 | 12.7 | |
• Mixed | 39.1 | 32.4 | |
Severity (%) | 0.630* | ||
• Mild | 34.8 | 40.6 | |
• Moderate | 43,5 | 43,5 | |
• Severe | 21.7 | 15.9 | |
Exacerbations per years | 0.82 (0.59-1.05) | 0.92 (0.67-1.17) | 0.642** |
Visits HC due COPD | 1.56 (1.15-1.97) | 2.04 (1.54-2.54) | 0.162** |
Treatment (%) | |||
• Anticholinergic | 77 | 77.8 | 0.914* |
• Beta-2 adrenergic | 79.7 | 80.6 | 0.900* |
• Inhaled corticosteroids | 74.3 | 66.7 | 0.310* |
• Xanthine | 6.8 | 9.7 | 0.514* |
Number of Devices (%) | 0.913* | ||
• 1 | 29.7% | 30.6% | |
• 2/more | 70.3% | 69.4% | |
SGRQ (scores) | |||
Total | 39.53 (35,42-43.64) | 35.32 (31.35-39.29) | 0.152** |
• Activity | 52.05 (48.12-57.98) | 50.62 (45.83-55.4) | 0.49** |
• Symptoms | 42.74 (38.14-47.34) | 39.62 (35.21-44.03) | 0.341** |
• Impact | 30.66 (26.45-34.87) | 25.46 (21.41-29.51) | 0.085** |
EuroQoL5D-3 L (%without problem) | |||
• Mobility | 54.1 | 59.7 | 0.489* |
• Self-care | 82.4 | 86.1 | 0.542* |
• Perform main, family or leisure activities | 77 | 80.6 | 0.601* |
• Anxious or depressed | 40.5 | 50 | 0.099* |
• Pain or discomfort | 64.9 | 70.8 | 0.207* |